Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Cell and Developmental Biology
|
July 25, 2022
<i>AP3S1</i> is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
Gujie Wu, Mianxiong Chen, Hefei Ren, et al.
Journal of Clinical Laboratory Analysis
|
July 15, 2022
Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer
Sai Chen, Hefei Ren, Xiaomin Zhang, et al.
Frontiers in Genetics
|
September 12, 2022
m<sup>5</sup>C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma
Hefei Ren, Chang Liu, Hongkun Wu, et al.
Frontiers in Oncology
|
April 3, 2023
Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
Gujie Wu, Qin Hu, Hongyu Chen, et al.
Clinical and Experimental Medicine
|
July 17, 2025
DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis
Huiquan Wang, Jiafeng Zhang, Lei Chen, et al.
Journal of Clinical Medicine
|
February 11, 2023
Application of Nonlinear Models Combined with Conventional Laboratory Indicators for the Diagnosis and Differential Diagnosis of Ovarian Cancer
Tongshuo Zhang, Aibo Pang, Jungang Lyu, et al.
Cancer Cell International
|
March 2, 2024
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA sequence analysis
Hefei Ren, Chang Liu, Cheng Zhang, et al.
Molecular and Cellular Probes
|
May 24, 2026
The Role of RNA Modifications in the Pathological Mechanisms and Therapeutic Targeting of Multiple Myeloma
Hao Chen, Hefei Ren, Xin Wang, et al.
Frontiers in Pharmacology
|
February 19, 2025
TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
Juntao Qi, Mingming Zhou, Na Yang, et al.
Cellular Signalling
|
September 30, 2023
Unraveling the molecular crosstalk and immune landscape between COVID-19 infections and ischemic heart failure comorbidity: New insights into diagnostic biomarkers and therapeutic approaches
Gujie Wu, Jiabin Zhou, Hefei Ren, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Cell and Developmental Biology
|
July 25, 2022
<i>AP3S1</i> is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
Gujie Wu, Mianxiong Chen, Hefei Ren, et al.
Journal of Clinical Laboratory Analysis
|
July 15, 2022
Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer
Sai Chen, Hefei Ren, Xiaomin Zhang, et al.
Frontiers in Genetics
|
September 12, 2022
m<sup>5</sup>C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma
Hefei Ren, Chang Liu, Hongkun Wu, et al.
Frontiers in Oncology
|
April 3, 2023
Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
Gujie Wu, Qin Hu, Hongyu Chen, et al.
Clinical and Experimental Medicine
|
July 17, 2025
DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis
Huiquan Wang, Jiafeng Zhang, Lei Chen, et al.
Journal of Clinical Medicine
|
February 11, 2023
Application of Nonlinear Models Combined with Conventional Laboratory Indicators for the Diagnosis and Differential Diagnosis of Ovarian Cancer
Tongshuo Zhang, Aibo Pang, Jungang Lyu, et al.
Cancer Cell International
|
March 2, 2024
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA sequence analysis
Hefei Ren, Chang Liu, Cheng Zhang, et al.
Molecular and Cellular Probes
|
May 24, 2026
The Role of RNA Modifications in the Pathological Mechanisms and Therapeutic Targeting of Multiple Myeloma
Hao Chen, Hefei Ren, Xin Wang, et al.
Frontiers in Pharmacology
|
February 19, 2025
TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
Juntao Qi, Mingming Zhou, Na Yang, et al.
Cellular Signalling
|
September 30, 2023
Unraveling the molecular crosstalk and immune landscape between COVID-19 infections and ischemic heart failure comorbidity: New insights into diagnostic biomarkers and therapeutic approaches
Gujie Wu, Jiabin Zhou, Hefei Ren, et al.
Page
of 2